Clinical trials are more connected and more closely examined than ever. Inspection readiness isn’t a last-minute document ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

Covariate-adaptive randomization represents an advanced methodology in the design of clinical trials, ensuring a balanced distribution of prognostic factors among treatment groups. This approach ...

Randomised clinical trials (RCTs) remain the gold standard in evaluating therapeutic interventions, ensuring that treatment effects are not confounded by systematic errors. Central to these trials is ...

The S2302 Pragmatica-Lung trial, led by the SWOG and run through the National Cancer Institute's National Clinical Trials Network, is a pragmatic registrational-intent study for advanced non–small ...

"Covariate adjustment" in the randomized trial context refers to an estimator of the average treatment effect that adjusts for chance imbalances between study arms in baseline variables (called ...

Innovations in clinical trial designs and tools have the potential to unlock a new era of research that is more convenient for patients, more reflective of real-world treatment conditions, and more ...

The pharmaceutical industry has evolved significantly in the past few decades to better meet the needs of today’s patients. Since I left my medical practice to join the industry 15 years ago, the role ...

(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 18 June 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company ...

In today's fast-paced and ever-evolving landscape of clinical trials, the ability to efficiently analyze and visualize data has become paramount. The vast amounts of data generated from these trials ...

Paul Meier, the statistician who revolutionized clinical trials in the United States, died last Sunday (August 7) from complications following a stroke, according to the New York Times. He was ...

Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma ...